Immunogenicity and safety of mixed COVID-19 vaccine regimens in patients with immune-mediated inflammatory diseases: a single-centre prospective cohort study

Immunogenicity and safety of mixed COVID-19 vaccine regimens in patients with immune-mediated inflammatory diseases: a single-centre prospective cohort study

Objective Among persons with immune-mediated inflammatory diseases (IMIDs) who received SARS-CoV-2 vaccines, we compared postvaccine antibody responses and IMID disease activity/states.Design Single-centre prospective cohort study.Setting Specialty ambulatory clinics in central Canada.Participants P...

Full description

Bibliographic Details
Main Authors:	Carol A Hitchon, Charles N Bernstein, Ruth Ann Marrie, John Kim, Sheila F O’Brien, Christine Mesa, Catherine Card
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-05-01
Series:	BMJ Open
Online Access:	https://bmjopen.bmj.com/content/13/5/e071397.full

Similar Items

Sex differences evident in elevated anxiety symptoms in multiple sclerosis, inflammatory bowel disease, and rheumatoid arthritis
by: Jerlin Joyees, et al.
Published: (2023-11-01)

Support for a non-therapist assisted, Internet-based cognitive-behavioral therapy (iCBT) intervention for mental health in rheumatoid arthritis patients
by: Caitlin Blaney, et al.
Published: (2021-04-01)

The association of fatigue, pain, depression and anxiety with work and activity impairment in immune mediated inflammatory diseases.
by: Murray W Enns, et al.
Published: (2018-01-01)

Immunogenicity of biologics in inflammatory bowel disease
by: Séverine Vermeire, et al.
Published: (2018-01-01)

Well-being and flourishing mental health in adults with inflammatory bowel disease, multiple sclerosis and rheumatoid arthritis in Manitoba, Canada: a cross-sectional study
by: Scott B Patten, et al.
Published: (2023-06-01)

Characterization of Autoantigens Targeted by Anti-Citrullinated Protein Antibodies In Vivo: Prominent Role for Epitopes Derived from Histone 4 Proteins.
by: Xiaobo Meng, et al.
Published: (2016-01-01)

Immunogenicity and reactogenicity of accelerated regimens of fractional intradermal COVID-19 vaccinations
by: Suvimol Niyomnaitham, et al.
Published: (2023-01-01)

Evaluation of the immunogenicity of a promising vaccine regimen to identify immune correlates of protection
by: Pinpathomrat, N
Published: (2018)

Switching to second line MS disease-modifying therapies is associated with decreased relapse rate
by: James John Marriott, et al.
Published: (2023-09-01)

Development and Internal Validation of a Disability Algorithm for Multiple Sclerosis in Administrative Data
by: Ruth Ann Marrie, et al.
Published: (2021-11-01)

Altered voxel-based and surface-based morphometry in inflammatory bowel disease
by: Jennifer Kornelsen, et al.
Published: (2023-10-01)

A comparative study of the gut microbiota in immune-mediated inflammatory diseases—does a common dysbiosis exist?
by: Jessica D. Forbes, et al.
Published: (2018-12-01)

Immunogenicity, safety and antibody persistence of a purified vero cell cultured rabies vaccine (Speeda) administered by the Zagreb regimen or Essen regimen in post-exposure subjects
by: Nianmin Shi, et al.
Published: (2017-06-01)

Safety and Immunogenicity of Homologous and Heterologous Adenoviral-Vectored and mRNA COVID-19 Vaccine Regimens in Radiotherapy Patients
by: Anussara Prayongrat, et al.
Published: (2023-06-01)

Comparative assessment of the immunogenicity of various revaccination regimens against the SARS-CoV-2
by: O. M. Drapkina, et al.
Published: (2023-01-01)

Safety and immunogenicity of a heterologous prime-boost Ebola virus vaccine regimen in healthy adults in the United Kingdom and Senegal
by: Venkatraman, N, et al.
Published: (2018)

Influence of Dosing Regimen and Adjuvant Type on the Immunogenicity of Novel Recombinant Zika Virus-Like Particles
by: Gabriela Brzuska, et al.
Published: (2023-02-01)

Attitudes of people with multiple sclerosis toward brain donation
by: Ruth Ann Marrie, et al.
Published: (2023-01-01)

Comparing the MSIS-29 and the Health Utilities Index Mark III in Multiple Sclerosis
by: Ruth Ann Marrie, et al.
Published: (2021-12-01)

Immunogenicity of cholera vaccination in children with inflammatory bowel disease
by: Łukasz Dembiński, et al.
Published: (2021-08-01)

Golimumab in the treatment of inflammatory diseases: A role of immunogenicity
by: D. E. Karateev
Published: (2016-01-01)

Are Canadian General Internal Medicine training program graduates well prepared for their future careers?
by: Snell Linda, et al.
Published: (2006-11-01)

Immunogenic Eimeria tenella glycosylphosphatidylinositol-anchored surface antigens (SAGs) induce inflammatory responses in avian macrophages.
by: Yock-Ping Chow, et al.
Published: (2011-01-01)

Safety and immunogenicity of heterologous COVID-19 vaccine regimens to deal with product shortage: A randomised clinical trial in an elderly population
by: M.A. Kundro, et al.
Published: (2022-12-01)

Safety and Cross-Variant Immunogenicity of a Three-dose COVID-19 mRNA Vaccine Regimen in Kidney Transplant Recipients
by: Filippo Massa, PhD, et al.
Published: (2021-11-01)

Usage and Usability of a National e-Library for Chemotherapy Regimens: Mixed Methods Study
by: AnnSofie Fyhr, et al.
Published: (2022-02-01)

Use of Benzodiazepines and Z-Drugs in Multiple Sclerosis
by: Ruth Ann Marrie, et al.
Published: (2022-04-01)

Differences in Immunogenicity of Three Different Homo- and Heterologous Vaccination Regimens against SARS-CoV-2
by: Robert Daniel Heinrich Markewitz, et al.
Published: (2022-04-01)

Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: a prospective cohort study
by: Nasamon Wanlapakorn, et al.
Published: (2022-01-01)

A comparative analysis of graduate preparedness for a career in General Internal Medicine before and after national subspecialty recognition to inform curricular changes: have we met the mark?
by: Samantha Halman, et al.
Published: (2023-03-01)

Anti-inflammatory drugs and immunogenicity of vaccines in patients with rheumatic diseases
by: B. S. Belov, et al.
Published: (2021-12-01)

Bacterial Immunogenicity Is Critical for the Induction of Regulatory B Cells in Suppressing Inflammatory Immune Responses
by: Jan Kevin Maerz, et al.
Published: (2020-01-01)

Vascular comorbidity is associated with decreased cognitive functioning in inflammatory bowel disease
by: Ronak Patel, et al.
Published: (2023-03-01)

Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers.
by: Vuola, J, et al.
Published: (2005)

Qualitative differences in cellular immunogenicity elicited by hepatitis C virus T-Cell vaccines employing prime-boost regimens.
by: Wendy G Tan, et al.
Published: (2017-01-01)

Production and Immunogenicity of Soluble Plant-Produced HIV-1 Subtype C Envelope gp140 Immunogens
by: Emmanuel Margolin, et al.
Published: (2019-10-01)

Post-marketing safety experience of vedolizumab in older patients with inflammatory bowel disease
by: Travis, S, et al.
Published: (2018)

Safety and immunogenicity of novel 5T4 viral vectored vaccination regimens in early stage prostate cancer: A phase I clinical trial
by: Cappuccini, F, et al.
Published: (2020)

Immunogenicity and Safety of the Three-Dose COVID-19 Vaccine Regimen in Patients Receiving Renal Replacement Therapy: A Systematic Review and Meta-Analysis
by: Becky Mingyao Ma, et al.
Published: (2024-01-01)

Safety and immunogenicity of rabies vaccine as 4 - dose Essen Intramuscular regimen for post exposure prophylaxis: A non - randomized, comparative controlled study
by: Ravish S. Haradanahalli, et al.
Published: (2021-08-01)